Metraipolis › archive › dc_d7ac2cec06c8

Case Report: Successful management of refractory SAPHO syndrome with guselkumab-upadacitinib combination — Europe PMC PMID:41798946

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798946
DOI
10.3389/fimmu.2026.1745464
License (as archived)
solo-consultazione
Archived
2026-11-05T14:24:23.033Z
SHA-256 of the archived text
9798a6d46ca7c421833090ddff2ac68961138b68e199b4efb95206d5190ee88d
Stable URL of this page
https://metraipolis.com/documento/dc_d7ac2cec06c8

How to cite

Case Report: Successful management of refractory SAPHO syndrome with guselkumab-upadacitinib combination — Europe PMC PMID:41798946 — Europe PMC (en), https://europepmc.org/article/MED/41798946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7ac2cec06c8 (Metraipolis archive dc_d7ac2cec06c8, sha256 9798a6d46ca7c421833090ddff2ac68961138b68e199b4efb95206d5190ee88d)
BibTeX
@misc{dcd7ac2cec06c8,
  title = {Case Report: Successful management of refractory SAPHO syndrome with guselkumab-upadacitinib combination — Europe PMC PMID:41798946},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798946},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7ac2cec06c8; sha256 9798a6d46ca7c421833090ddff2ac68961138b68e199b4efb95206d5190ee88d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798946. Agents can read the archived copy with the MCP tool read_document.